Italian consensus statement on paediatric HIV infection. - Wikidata - wikimedia - TriplyDB

Italian consensus statement on paediatric HIV infection.

Italian consensus statement on paediatric HIV infection.

http://www.wikidata.org/entity/Q37761853

about

Post-licensing safety of fosamprenavir in HIV-infected children in Europe.Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort.Antiretroviral treatment adherence in childhood and adolescence: multidisciplinary team as an associated factor in Brazil.

P2860

Q34692768-01BC5BB4-370B-4661-A52F-C0E73CEF891D Q39967074-785B702D-2B83-42C4-BDC0-4B0DA8F7B469 Q44550936-AD740DC6-EBE0-40BB-BD8C-5CAAFC0B1FE6

P2860

Italian consensus statement on paediatric HIV infection.

http://www.wikidata.org/entity/Q37761853

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Italian consensus statement on paediatric HIV infection.

@en

Italian consensus statement on paediatric HIV infection.

@nl

type

label

Italian consensus statement on paediatric HIV infection.

@en

Italian consensus statement on paediatric HIV infection.

@nl

prefLabel

Italian consensus statement on paediatric HIV infection.

@en

Italian consensus statement on paediatric HIV infection.

@nl

P1433

Q37761853-515AE8B4-55B4-4B27-A542-F04A3A409FD3

P1476

Q37761853-F21C381F-CD72-473A-977F-F301E62D3094

P2093

Q37761853-16BF037F-74B1-487A-AC81-F6B855AD1C9A

Q37761853-1D6340AF-05A0-4E64-BB3B-147BBAF21782

Q37761853-2430F59B-FA40-4C2B-8090-EC75AE62D88A

Q37761853-27E1FC5C-3D99-4A4C-9498-39B1ADDF6336

Q37761853-2D572FB3-2FEF-42EF-A5FF-72150E0C20EB

Q37761853-36D4EE0C-820B-4265-AABF-A59FD211EC3D

Q37761853-37CC9A8C-9F37-46EA-938C-A560F7523BD4

Q37761853-47BF61B4-1073-47F2-AA1F-32B67479A4E8

Q37761853-56AD7968-F4ED-46CE-8A55-496604F42CC2

Q37761853-603DEC89-ADCE-46AD-BBC9-BBDEB2C1A67F

P2860

Q37761853-0097918E-69B1-4218-838F-16C794060901

Q37761853-19E6CD03-F23F-4214-BA32-27EE44ECE24A

Q37761853-6BE2A7E2-2DA0-4925-9C0A-AF47C3DB353D

Q37761853-7AEFC89A-59A0-4009-A433-C0949687E026

Q37761853-7EBF9383-F48E-4B81-A31B-263CE4F9EBBB

Q37761853-A8100B9D-72CE-492B-B6D0-5B0640E7FCE8

Q37761853-E58C0A21-DA9B-461A-BAF1-E7DCAC32C2A6

P2888

Q37761853-08D629E5-F679-4DC8-A3B0-AC5534D99536

P304

Q37761853-EB0FEC65-1BA7-4FA9-BA31-A5F91E449C97

P31

Q37761853-E2072C63-EB75-473D-B8E5-CCB7FA492595

P356

Q37761853-D0AE1B85-B2B6-4024-8B9F-294B73017A3F

P433

Q37761853-1D7928D4-9E3E-4813-BCE4-1AD270F53CFC

P478

Q37761853-13257058-C6CC-4B91-AAA1-A1291A1F1788

P50

Q37761853-4575B9FF-F277-4DF2-B0E3-39F29BEA6703

Q37761853-5A271AC8-ADBF-4BB5-9D59-280F4F15FC9F

Q37761853-5D9B671F-7375-4BE5-9CB2-C0D13E30060E

Q37761853-6552F6E4-946D-4AD4-8BAF-8D39D5A1A6F0

Q37761853-69F17FC0-A13A-42F1-A2AC-715DC1391FE2

Q37761853-94DF5C3D-D144-4F0B-B531-4F51AF37D24D

Q37761853-9F7D520B-AAEC-4ED0-837A-A2293687015F

Q37761853-AE9995B3-72EC-4B13-AB0F-D09887299D4B

Q37761853-CB2C8F27-7A0F-4CB9-8C90-A4C3E3435388

Q37761853-DFD15745-8207-4C92-9B47-5F531B2F12F9

P577

Q37761853-C8283EB6-A0D7-47D4-9BAA-64CD6C27A9B9

P698

Q37761853-97E0D4C0-DD8C-4B50-AF53-893CF418774A

P921

Q37761853-4FF95252-5CFB-4D9B-9F80-AD3EE9A2742C

P356

S15010-010-0020-5

P1433

P1476

Italian consensus statement on paediatric HIV infection

@en

P2093

A Antinori

http://www.w3.org/2001/XMLSchema#string

A Franco

http://www.w3.org/2001/XMLSchema#string

A Guarino

http://www.w3.org/2001/XMLSchema#string

A Martino

http://www.w3.org/2001/XMLSchema#string

A Viganò

http://www.w3.org/2001/XMLSchema#string

A d'Arminio Monforte

http://www.w3.org/2001/XMLSchema#string

C Gabiano

http://www.w3.org/2001/XMLSchema#string

C Giaquinto

http://www.w3.org/2001/XMLSchema#string

C Gotta

http://www.w3.org/2001/XMLSchema#string

F Fatuzzo

http://www.w3.org/2001/XMLSchema#string

P2860

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.

Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.

Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine.

Barriers to HAART adherence among human immunodeficiency virus-infected adolescents.

Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis.

When the time comes to talk about HIV: factors associated with diagnostic disclosure and emotional distress in HIV-infected children.

P2888

s15010-010-0020-5

P304

301-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S15010-010-0020-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Susanna Esposito

Gian Vincenzo Zuccotti

Stefania Bernardi

Raffaele Badolato

Orazio Genovese

Guido Castelli-Gattinara

Antonietta Giannattasio

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20514509

http://www.w3.org/2001/XMLSchema#string

P921